A Randomised, Single-Blind, Placebo-Controlled, Single-Centre, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Interaction After Single Ascending Oral Doses of AZD6714 in Healthy Male Volunteers and Male Type II Diabetic Patients.

Next Previous
Trial Profile

A Randomised, Single-Blind, Placebo-Controlled, Single-Centre, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Interaction After Single Ascending Oral Doses of AZD6714 in Healthy Male Volunteers and Male Type II Diabetic Patients.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 06 Dec 2010

At a glance

  • Drugs AZD 6714 (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions

    • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 06 Dec 2010 Planned end date changed from 1 Dec 2009 to 1 Sep 2009 as reported by ClinicalTrials.gov.
    • 30 Oct 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top